Comments
Loading...

Avalo Therapeutics

AVTXNASDAQ
Logo brought to you by Benzinga Data
$11.50
0.65.50%
Pre-Market: Nov 18, 4:00 PM EDT
62.5%
Overview Rating
Good
Technicals Analysis
33
0100
Financials Analysis
80
0100

Avalo Therapeutics (NASDAQ:AVTX) Stock Quotes, Forecast and News Summary

Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.

80%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.6
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.143.00 / 35.78K
Day Range- - -
52 Wk Range3.95 - 34.46
Market Cap$120.33M
P/E Ratio0.12
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
0.1%
Days to Cover1

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AVTX
OTLK

FAQ

Q

How do I buy Avalo Therapeutics (AVTX) stock?

A

You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Avalo Therapeutics (AVTX) competitors?

Q

What is the forecast, or price target, for Avalo Therapeutics (AVTX) stock?

A

Avalo Therapeutics has a consensus price target of $12.92.

Q

What is the current price for Avalo Therapeutics (AVTX)?

A

The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $11.5 last updated November 18, 2024 at 4:00 PM EST.

Q

Does Avalo Therapeutics (AVTX) pay a dividend?

A

There are no upcoming dividends for Avalo Therapeutics.

Q

When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?

A

Avalo Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Avalo Therapeutics (AVTX) going to split?

A

There is no upcoming split for Avalo Therapeutics.

Q

What sector and industry does Avalo Therapeutics (AVTX) operate in?

A

Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch